Cargando…
Treatment with Nasal Neuro-EPO Improves the Neurological, Cognitive, and Histological State in a Gerbil Model of Focal Ischemia
Vascular illness of the brain constitutes the third cause of death and the first cause of disability in Cuba and many other countries. Presently, no medication has been registered as a neuroprotector. Neuroprotection with intranasal Neuro-EPO (EPO, erythropoietin) has emerged as a multifunctional th...
Autores principales: | Rodríguez Cruz, Yamila, Yuneidys Mengana, Támos, Muñoz Cernuda, Adriana, Subirós Martines, Nelvis, González-Quevedo, Alina, Sosa Testé, Iliana, García Rodríguez, Julio César |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
TheScientificWorldJOURNAL
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763740/ https://www.ncbi.nlm.nih.gov/pubmed/21103798 http://dx.doi.org/10.1100/tsw.2010.215 |
Ejemplares similares
-
Dose Effect Evaluation and Therapeutic Window of the Neuro-EPO Nasal Application for the Treatment of the Focal Ischemia Model in the Mongolian Gerbil
por: Teste, Iliana Sosa, et al.
Publicado: (2012) -
Neuroprotective Effects of neuroEPO Using an In Vitro Model of Stroke
por: Fernando, Garzón, et al.
Publicado: (2018) -
Nasal administration of the neuroprotective candidate NeuroEPO to healthy volunteers: a randomized, parallel, open-label safety study
por: Santos-Morales, Orestes, et al.
Publicado: (2017) -
Neuroprotective effect of Neuro-EPO in neurodegenerative diseases: “Alea jacta est”
por: Rama, Ramón, et al.
Publicado: (2019) -
The Nasal Route as a Potential Pathway for Delivery of Erythropoietin in the Treatment of Acute Ischemic Stroke in Humans
por: García-Rodríguez, Julio Cesar, et al.
Publicado: (2009)